Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01268189 · ClinicalTrials.gov registry record · NA

Evaluation of Oxygen Diffusion Dressing for Accelerating Healing of Donor Site and Other Wounds

A NA study, sponsored by United States Army Institute of Surgical Research.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT01268189 is a NA study that has completed, run by United States Army Institute of Surgical Research. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01268189, a NA study, has completed, sponsored by United States Army Institute of Surgical Research.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

This is a single-center, prospective, randomized, and controlled study to evaluate the effectiveness of OxyBand Dressing for the use as a dressing for autogenous skin donor sites compared to our current standard donor site dressing (Xeroform). Hypothesis is that the mean healing time for wounds treated with the OxyBand dressing will be less than the mean healing time for wounds treated with the Xeroform dressing.

Interventions

  • DEVICE Oxygen diffusing dressing
  • DEVICE Standard of care dressing

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2010-08
Est. Completion 2012-03
Phase NA

What the Registry Record Tells You About NCT01268189

The ClinicalTrials.gov registry entry for NCT01268189 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is United States Army Institute of Surgical Research, which has 17 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Oxygen diffusing dressing is the first listed.

NCT01268189 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01268189 about?

NCT01268189 is a clinical study titled "Evaluation of Oxygen Diffusion Dressing for Accelerating Healing of Donor Site and Other Wounds". This is a single-center, prospective, randomized, and controlled study to evaluate the effectiveness of OxyBand Dressing for the use as a dressing for autogenous skin donor sites compared to our current standard donor site dressing (Xeroform). Hypothesis is that the mean healing time for wounds trea...

What is the current status of trial NCT01268189?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2010-08. Estimated completion is 2012-03.

What interventions are being tested in trial NCT01268189?

The interventions under investigation include: Oxygen diffusing dressing (DEVICE), Standard of care dressing (DEVICE).

Who is sponsoring clinical trial NCT01268189?

This trial is sponsored by United States Army Institute of Surgical Research, which has 17 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.